Related Experiment Video
Updated: Sep 2, 2025

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
COVID-19-associated fungal infections
Martin Hoenigl1,2,3, Danila Seidel4,5, Rosanne Sprute4,5
1Division of Infectious Diseases, Department of Internal Medicine, Medical University of Graz, Graz, Austria. hoeniglmartin@gmail.com.
Abstract:
Coronavirus disease 2019 (COVID-19)-associated invasive fungal infections are an important complication in a substantial number of critically ill, hospitalized patients with COVID-19. Three groups of fungal pathogens cause co-infections in COVID-19: Aspergillus, Mucorales and Candida species, including Candida auris. Here we review the incidence of COVID-19-associated invasive fungal infections caused by these fungi in low-, middle- and high-income countries. By evaluating the epidemiology, clinical risk factors, predisposing features of the host environment and immunological mechanisms that underlie the pathogenesis of these co-infections, we set the scene for future research and development of clinical guidance.
Insights
Invasive fungal infections are a significant complication for hospitalized COVID-19 patients. This review examines fungal co-infections caused by Aspergillus, Mucorales, and Candida species, including Candida auris.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Critical Care Medicine
Background:
- Hospitalized patients with Coronavirus disease 2019 (COVID-19) face a substantial risk of invasive fungal infections.
- Co-infections with fungal pathogens, including Aspergillus, Mucorales, and Candida species (e.g., Candida auris), are increasingly recognized complications.
Purpose of the Study:
- To review the incidence of COVID-19-associated invasive fungal infections across different income countries.
- To evaluate the epidemiology, clinical risk factors, host environment, and immunological mechanisms of these co-infections.
- To provide a foundation for future research and clinical guidance development.
Main Methods:
- Systematic literature review of COVID-19-associated invasive fungal infections.
- Analysis of epidemiological data from low-, middle-, and high-income countries.
- Evaluation of host-related factors and immunological responses.
Main Results:
- Invasive fungal infections are a notable complication in critically ill COVID-19 patients.
- Aspergillus, Mucorales, and Candida species are the primary fungal pathogens involved in COVID-19 co-infections.
- Incidence and risk factors vary globally, necessitating tailored clinical approaches.
Conclusions:
- Understanding the multifaceted nature of fungal co-infections in COVID-19 is crucial for patient management.
- Further research into pathogenesis and global epidemiology is needed to inform clinical guidelines.
- Effective strategies are required to mitigate the impact of these serious co-infections.
Related Concept Videos
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Fungal Phylum Ascomycota
Fungal Phylum Basidiomycota
Overview of Fungi

